• Founded
  • 2015
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

BIOSQUAL General Information


Developer of analogues of squalamine. The company develops series of analogues of squalamine and pharmaceutical formulations for clinical use.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 10, rue Clapier
  • 13001 Marseille
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BIOSQUAL Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view BIOSQUAL’s complete valuation and funding history, request access »

BIOSQUAL Executive Team (1)

Name Title Board Seat Contact Info
Séverine Pitel President
To view BIOSQUAL’s complete executive team members history, request access »

BIOSQUAL Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Incubateur Impulse Accelerator/Incubator 000 0000 000000 0
To view BIOSQUAL’s complete investors history, request access »